2-[18F]FDG-PET/CT最大SUV与CT衰减在引导骨活检中的效用比较
该IRB批准的回顾性研究纳入388例在骨活检前6周内接受2-[18F]FDG PET/CT和CT检查的患者,比较PET/CT参数与CT参数引导骨活检的准确性。结果显示,对于骨病灶活检,SUVmax的ROC曲线(AUC=0.6827)优于delta CT衰减(AUC=0.5766,p=0.032)和绝对delta CT衰减(AUC=0.5491,p=0.006),但与CT衰减(AUC=0.5894,p=0.061)和T/L比值(AUC=0.6778,p=0.774)无显著差异;SUVmax阈值5.25预测恶性的准确度0.713、敏感度0.766、特异度0.549。骨髓活检中这些变量均不能预测恶性(p>0.05)。
要点
- 骨病灶活检中SUVmax预测恶性的AUC为0.6827,优于delta CT衰减和绝对delta CT衰减。
- SUVmax阈值5.25预测骨病灶活检恶性的准确度0.713、敏感度0.766、特异度0.549。
- 骨髓活检中SUVmax、T/L比值及CT参数均不能预测恶性(p>0.05)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to compare the accuracy of PET/CT parameters with CT parameters for directing bone biopsies.
METHODS: The study was an IRB-approved retrospective study of 388 patients who underwent both 2-[18F] FDG PET/CT and CT within 6 weeks before a bone biopsy. Age, sex, cancer type, lesion length, SUVmax, tumor to liver (T/L) ratio, CT attenuation, difference in CT attenuation between the lesion and normal bone (delta CT attenuation), and the absolute delta CT attenuation were used as predictors. T tests and chi-squared tests were used to compare variables. DeLong's test was used to compare receiver operator characteristic (ROC) curves.
RESULTS: We reviewed the data from 388 patients. Of these, 295 patients had bone lesion biopsies, and 93 patients had bone marrow aspirations/biopsies. Biopsies of larger bone lesions (p = 0.033) and bone lesions with higher SUVmax (p = 0.005) were more likely to show malignancy. For bone lesions, the ROC curve for the SUVmax (AUC = 0.6827) was better than the ROC curves for delta CT attenuation (AUC = 0.5766, p = 0.032) and absolute delta CT attenuation (AUC = 0.5491, p = 0.006), but not significantly better than the ROC curves for CT attenuation (AUC = 0.5894, p = 0.061) and T/L ratio (AUC = 0.6778, p = 0.774). A threshold SUVmax of 5.25 had an accuracy of 0.713, sensitivity of 0.766, and specificity of 0.549 to predict malignancy in bone lesion biopsies. None of these variables predicted malignancy in bone marrow biopsies (p > 0.05 for all).
CONCLUSIONS: Metabolic 2-[18F]FDG PET/CT parameters have more clinical impact for planning bone biopsies as compared to CT parameters.
KEY POINTS: • The 2-[18F]FDG PET/CT measurement (SUVmax) has more clinical impact for planning bone biopsies as compared to CT measurements. • Neither the change in CT attenuation of the lesion relative to normal bone nor the absolute value of this change was a significant predictor of malignancy. • 2-[18F]FDG PET/CT may have clinical benefit and an additional role in directing bone biopsies.
引用
- Sebro R, Ashok SS. The utility of 2-[18F]FDG-PET/CT maximum SUV versus CT attenuation for directing bone biopsies. Eur Radiol. 2021. PMID: 33686475. doi:10.1007/s00330-021-07770-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。